XCL1 antibody (AA 22-114)

Catalog No. ABIN562827

This anti-XCL1 antibody is a Mouse Polyclonal antibody detecting XCL1 in WB and ELISA. Suitable for Human. This Primary Antibody has been cited in 1 publication.

Quick Overview for XCL1 antibody (AA 22-114) (ABIN562827)

Target: XCL1 (Chemokine (C Motif) Ligand 1 (XCL1))

Reactivity: Human

Host: Mouse

Clonality: Polyclonal

Conjugate: This XCL1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Product Details anti-XCL1 Antibody

Binding Specificity: AA 22-114

Purpose: Mouse polyclonal antibody raised against a partial recombinant XCL1.

Sequence: VGSEVSDKRT CVSLTTQRLP VSRIKTYTIT EGSLRAVIFI TKRGLKVCAD PQATWVRDVV RSMDRKSNTR NNMIQTKPTG TQQSTNTAVT LTG

Cross-Reactivity: Human

Characteristics: Antibody Reactive Against Recombinant Protein.

Immunogen: XCL1 (NP_002986, 22 a.a. ~ 114 a.a) partial recombinant protein with GST tag.

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 50 % glycerol

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

References for anti-XCL1 antibody (ABIN562827)

Venetz, Ponzoni, Schiraldi, Ferreri, Bertoni, Doglioni, Uguccioni: "Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells." in: International journal of cancer. Journal international du cancer, Vol. 127, Issue 10, pp. 2300-12, (2010) (PubMed).

Target Details for XCL1

Target: XCL1 (Chemokine (C Motif) Ligand 1 (XCL1))

Alternative Name: XCL1

Background: Full Gene Name: chemokine (C motif) ligand 1
Synonyms: ATAC,LPTN,LTN,SCM-1,SCM-1a,SCM1,SCYC1

Gene ID: 6375

NCBI Accession: NM_002995

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation